Literature DB >> 12464486

The role of KasA and KasB in the biosynthesis of meromycolic acids and isoniazid resistance in Mycobacterium tuberculosis.

R A Slayden1, C E Barry.   

Abstract

Mycobacterium tuberculosis has two discrete beta-ketoacyl synthases encoded by kasA and kasB that are located in tandem within a five-gene operon that has been implicated in isoniazid-sensitivity and mycolic acid synthesis. We have developed an in vitro meromycolic acid synthase assay to elucidate the anabolic role of these enzymes. Overproduction of KasA and KasB individually and together in M. smegmatis enabled cell-free incorporation of [(14)C]malonyl-CoA into lipids whose chain length was dependent upon the M. tuberculosis elongating enzyme used. KasA specifically elongated palmitoyl-CoA to monounsaturated fatty acids that averaged 40 carbons in length. KasB hyperproduction in the presence of KasA produced longer chain multiunsaturated hydrocarbons averaging 54 carbons in length. These products comigrated with a synthetic standard of meromycolic acid and their production was sensitive to isoniazid, thiolactomycin, and triclosan. KasA mutations associated with isoniazid resistance produced an enzyme that had a diminished overall catalytic activity but conferred enhanced resistance to isoniazid. In vivo analysis confirmed that overexpression of each of the four mutant KasAs enhanced isoniazid resistance when compared to overexpression of wild-type KasA. These results suggest discrete anabolic roles for both KasA and KasB in mycolic acid synthesis and substantiate the involvement of KasA mutations in isoniazid resistance.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12464486     DOI: 10.1054/tube.2002.0333

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  32 in total

Review 1.  Microbial type I fatty acid synthases (FAS): major players in a network of cellular FAS systems.

Authors:  Eckhart Schweizer; Jörg Hofmann
Journal:  Microbiol Mol Biol Rev       Date:  2004-09       Impact factor: 11.056

Review 2.  Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Authors:  Barbara A Brown-Elliott; Kevin A Nash; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

Review 3.  Targeting InhA, the FASII enoyl-ACP reductase: SAR studies on novel inhibitor scaffolds.

Authors:  Pan Pan; Peter J Tonge
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

4.  Structure-activity relationships at the 5-position of thiolactomycin: an intact (5R)-isoprene unit is required for activity against the condensing enzymes from Mycobacterium tuberculosis and Escherichia coli.

Authors:  Pilho Kim; Yong-Mei Zhang; Gautham Shenoy; Quynh-Anh Nguyen; Helena I Boshoff; Ujjini H Manjunatha; Michael B Goodwin; John Lonsdale; Allen C Price; Darcie J Miller; Ken Duncan; Stephen W White; Charles O Rock; Clifton E Barry; Cynthia S Dowd
Journal:  J Med Chem       Date:  2006-01-12       Impact factor: 7.446

Review 5.  Targeting the formation of the cell wall core of M. tuberculosis.

Authors:  Clifton E Barry; Dean C Crick; Michael R McNeil
Journal:  Infect Disord Drug Targets       Date:  2007-06

6.  Substrate recognition by β-ketoacyl-ACP synthases.

Authors:  Janine G Borgaro; Andrew Chang; Carl A Machutta; Xujie Zhang; Peter J Tonge
Journal:  Biochemistry       Date:  2011-11-17       Impact factor: 3.162

7.  AccD6, a key carboxyltransferase essential for mycolic acid synthesis in Mycobacterium tuberculosis, is dispensable in a nonpathogenic strain.

Authors:  Jakub Pawelczyk; Anna Brzostek; Laurent Kremer; Bozena Dziadek; Anna Rumijowska-Galewicz; Marta Fiolka; Jaroslaw Dziadek
Journal:  J Bacteriol       Date:  2011-10-07       Impact factor: 3.490

Review 8.  Fatty acid biosynthesis in actinomycetes.

Authors:  Gabriela Gago; Lautaro Diacovich; Ana Arabolaza; Shiou-Chuan Tsai; Hugo Gramajo
Journal:  FEMS Microbiol Rev       Date:  2011-01-19       Impact factor: 16.408

9.  Protein dynamics in iron-starved Mycobacterium tuberculosis revealed by turnover and abundance measurement using hybrid-linear ion trap-Fourier transform mass spectrometry.

Authors:  Prahlad K Rao; G Marcela Rodriguez; Issar Smith; Qingbo Li
Journal:  Anal Chem       Date:  2008-08-09       Impact factor: 6.986

10.  A novel interaction linking the FAS-II and phthiocerol dimycocerosate (PDIM) biosynthetic pathways.

Authors:  Nicole A Kruh; Janine G Borgaro; Béla P Ruzsicska; Hua Xu; Peter J Tonge
Journal:  J Biol Chem       Date:  2008-08-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.